Speakers in Workshops
SPEAKERS IN WORKSHOP A: WHY NOT PRACTISE KNOWLEDGE? THE ART OF DISEASE PREVENTION
Cortney Price, Global Behavioural Change and Communication Coordinator, Antimicrobial Resistance, bio will be available shortly.
Leif Östman, Professor at Department of Education, Uppsala University, bio will be available shortly.
SPEAKERS IN WORKSHOP B: LOTS OF TALK BUT LITTLE ACTION: WHAT'S HINDERING IMPLEMENTATION OF INCENTIVES TO STIMULATE ANTIBIOTICS R&D?
Ursula Theuretzbacher is an expert for antibacterial drug research, discovery/development strategies and policies based on clinical and public health needs. Her broad area of expertise includes public and philanthropic funding strategies for antibacterial drug R&D and initiatives to recover the global pipeline, evaluation and comparative assessment of antibacterial drugs, and optimization of antibacterial therapy concepts. She was member of the coordinating group of the WHO project Priority Pathogen List for R&D and leading scientist for the Clinical and Preclinical Pipeline analysis, and development of Target Product Profiles at WHO.
Aidan Hollis studied at Cambridge University and the University of Toronto, where he obtained a PhD in economics. His research focuses on innovation and competition in pharmaceutical markets, and he has published over eighty peer-reviewed articles and two books in a range of fields of economics. He has provided expert reports and testimony in a variety of pharmaceutical-related cases in Federal, Appeals and Supreme Court cases in Canada, and has advised companies and governments. He served on the WHO Guideline Development Group on Antimicrobial Use in Food Animals and is currently on the Expert Advisory Group for the Global AMR R&D Hub. In recent years, he has made invited presentations at (among others) OECD, UNESCO, UN, World Bank, Harvard, Yale, Université Paris Descartes, and LSE.
Dr Chantal Morel is a health economist specialising in infectious diseases, and in issues related to antimicrobial resistance in particular. Her work revolves mainly around the use of new financing arrangements and incentives to bolster innovation in the antibiotic pipeline to produce better products, improve surveillance of resistance, support antibiotic stewardship and system-wide sustainable use measures, and increase access to antibiotics where there clinical need currently unmet by supply.
SPEAKERS IN WORKSHOP C: CONSUMER BAHAVIOUR AND ANTIBIOTIC RESISTANCE
Alberto Giubilini is a Senior Research Fellow on at the Oxford Uehiro Centre for Practical Ethics, University of Oxford. He has a PhD in Philosophy from the University of Milan, and prior to joining the Uehiro Centre he worked in Australia at Monash University, University of Melbourne and Charles Sturt University. He has published on different topics in bioethics and philosophy, including the ethics of vaccination, procreative choices, end of life decisions, organ donations, conscientious objection in healthcare, the concept of conscience, human enhancement, and the role of intuitions and of moral disgust in ethical arguments. He has published a book on The Ethics of Vaccination (Palgrave MacMillan 2019) and one in Italian on the ethics of end of life decisions (Morals in the Time of Bioethics, Le Lettere 2011), and he co-edited a book on The Ethics of Human Enhancement (Oxford University Press 2016)
SPEAKERS IN WORKSHOP D: RESISTANT BACTERIA IN THE ENVIRONMENT
Lenore Manderson AM is Distinguished Professor of Public Health and Medical Anthropology in the School of Public Health, University of the Witwatersrand, and an NRF A-rated scholar. She holds appointments also with Brown University, US, and Monash University, Australia. Her research and training focuses on inequality and the social context of infectious and chronic diseases, including on treatment regimes and the use and misuse of antibiotics, with field experience in Australia, Southeast and East Asia, and Africa. She has published some 750 books, articles, book chapters and reports, including Sickness and the State (1996) Surface Tensions (2011), Routledge Handbook of Medical Anthropology (2016, with Elizabeth Cartwright and Anita Hardon) and Connected Lives (2020, with Nolwazi Mkhwanazi). She chairs the External Research Review Group of the Social Innovations in Health Initiative of TDR (2015-) and is a member of the Board of Directors of the Society for Applied Anthropology (SfAA). In January 2020 she was admitted as a Member of the Order of Australia.
Dr. Suraj K. Tripathy is presently continuing as Associate Dean, School of Chemical Technology with a joint appointment with School of Biotechnology at Kalinga Institute of Industrial Technology (KIIT), Bhubaneswar. He leads Chemical & Bioprocess Engineering Group at KIIT which works on process integration and intensification for improving resource efficiency and sustainable public health. The major focus of his group is to design sustainable processes and decentralized devices for treatment of waste and/or drinking water. In particular, his group develops materials from low-cost secondary resources for photocatalytic disinfection of water borne multi drug resistant bacteria. He also works closely with industries and waste water treatment plants to investigate innovative strategies to minimize the discharge of pollutants to natural water bodies.
SPEAKERS IN WORKSHOP E: MAKING SENSE OF ANTIMICROBIAL RESISTANCE: COMMUNICATE FOR CHANGE
Denesha Brar: Communications Lead Wellcome Trust, UK, bio will be available shortly
Catherine Will is a Reader, Sociology of Science and Technology School of Law, Politics and Sociology at the University of Sussex. Her research examines social and health care organisations and technologies, drawing on Science and Technology Studies (STS) and political sociology. She is particularly interested in knowledge production - how people experiment or develop their understanding of their world - and the moments when knowledge claims are linked with the negotiation of standards or policies. She has worked at the London School of Economics, University of Cambridge and University of Sussex, she is on the editorial team of the Sociology of Health and Illness journal and was one of the founding editors of a blog on the politics, economics and sociology of health and health care (Cost of Living). She is currently on research leave working on a Wellcome Trust Investigator Award with the title 'Marginalisation and the microbe: how can we attend to health inequalities while mobilising against antimicrobial resistance’ (see website www.marginalisationandthemicrobe.org or @AMRInterrupted on social media).
SPEAKERS IN WORKSHOP F: CHILDREN IN THE WILD : POTENTIAL PERIL AND BENEFITS IN HUMAN-ANIMAL ENCOUNTERS
Caleb Mandikonza has a background in Biology and Education for Sustainable Development (ESD) and lectures in Science Education at the University of Witwatersrand, Johannesburg, South Africa. During his tenure as Capacity Building Manager at the Southern African Development Community’s Regional Environmental Education Programme (SADC REEP), Experiential Learning, which included ‘proximal’ encounters with ‘the natural world’ to unravel ‘patterns in nature’, was one key pedagogical approach to Environmental Education (EE). He currently works to integrate ESD in Life Sciences Education as part of his teacher education curriculum practice as well as continuing teacher professional development practice.
Dr. Kristina Osbjer is a veterinarian with a PhD from the Swedish University of Agricultural Sciences (SLU) and expertise on antimicrobial resistance/use, infectious disease control and multi-sector collaboration in low and middle-income countries. Her career begun in large and small animal clinical practice before she joined the Food and Agriculture Organization of the United Nations (FAO) in 2007, with the avian influenza programme in Lao PDR, followed by work at the regional office for Eastern Africa with zoonotic and transboundary disease outbreak management. In 2011, she returned to SLU for PhD-studies on zoonotic diseases before rejoining FAO in 2016 to head the Emergency Centre for Transboundary Animal Diseases in Cambodia. She is since 2019 splitting her time between the Department of Clinical Sciences at SLU where she’s engaged with research and capacity development on antimicrobial resistance/use in Asia and Africa and consultancies for FAO on antimicrobial resistance and infectious disease control in Asia.
SPEAKERS IN WORKSHOP G: Where are our antibiotics? Three possible solutions to address antibiotic shortages and improve antibiotics supply globally
- Richard Bergström, Vaccine Coordinator at Government Offices of Sweden. Bio will be available shortly.
Dr Maria Guevara is the new International Medical Secretary, after serving recently as a Senior Advisor on global health at MSF-OCG, with special interest on Planetary Health. Prior to this, she was the Senior Coordinator for Attacks on Healthcare. From 2012 to 2017, Maria was the MSF Regional Humanitarian Representative in Asia and served as a member of the Advisory Group on Reform for WHO’s Work in Outbreaks and Emergencies with Health and Humanitarian Consequences from July 2015 to January 2016. She is a SAFE STEPS First Aid Ambassador for a collaborative pan-Asia program to promote awareness and increase knowledge of first aid skills across the region.
Her work in the humanitarian sector began with MSF in Liberia in 2004. Since then she has held field roles in Guatemala, Haiti, DRC, Nigeria, Myanmar, the Philippines, Indonesia, Malaysia and South Sudan, in both emergency and stable settings. A Pulmonary and Critical Care Medicine specialist, Maria also holds a Diploma in Tropical Medicine and Hygiene from the Liverpool School of Tropical Medicine and a Master of Science in Global Health Policy from the London School of Hygiene and Tropical Medicine.
SPEAKERS IN WORKSHOP G: TEACHING AMR - SCHOOLS AS CHANGE AGENTS
Tracie Muraya is a Policy Officer at ReAct (Action on Antibiotic Resistance) Africa, where she advocates for, and supports development and implementation of member countries’ National Action Plans on antimicrobial resistance (AMR) based on policies that are informed through iterative evidence. Through her role she engages with different stakeholders at international, regional and national levels ranging from policy makers and healthcare professionals through to communities at grassroot level to catalyse action on AMR. She has also contributed to development of different regional and national policy documents. Tracie is a trained pharmacist with 15 years of experience in strengthening health systems and holds a Bachelor of Pharmacy degree from Rhodes University, South Africa and a Postgraduate Diploma in Public Health from the University of Liverpool. She is currently pursuing a Master’s in Public Health with specialization in Global Health Policy at the University of Suffolk.
- Dr Bjarne Bruun Jensen, Professor in health promotion and senior advisor at Steno Diabetes Center Copenhagen. Bio will be available shortly.